The H1 FY 2023 Ebos Group results were strong, thanks to a combination of acquired and organic growth.
EBOS Group (ASX: EBO)
The FY 2022 Ebos Group results show a decent defensive dividend stock, but ongoing capital investment will be required for growth.
I use watchlists with target desired buy prices to help me take advantage of market volatility in a calm and measured way.
The Ebos Group half year report showed decent growth, both organic and through acquisitions. But the Ebos share price is up, leading to a lower dividend yield.
The Ebos Group (ASX: EBO) retail equity offer has me considering if I want to increase my position, or arbitrage the discount for a profit.
ASX listed healthcare stock EBOS Group (ASX:EBO) reports solid earnings per share growth and has increased its dividend accordingly.
Here’s it’s defensive and why there is still good upside…
Reflections on the volatility and a stream of consciousness rumination on 5 stocks I like now.